<DOC>
	<DOCNO>NCT01638806</DOCNO>
	<brief_summary>Patients acute myocardial infarction ( AMI ) categorize accord electrocardiogram ( ECG ) finding : 1 ) patient ST-Elevation Myocardial Infarction ( STEMI ) , 2 ) patient Bundle Branch Block Myocardial Infarction ( BBBMI ) , 3 ) remain patient so-called NON-ST-Elevation Myocardial Infarction ( NONSTEMI ) . Patients STEMI BBBMI treat acute angioplasty ( PPCI=primary percutaneous coronary intervention ) , sooner PPCI perform low mortality . This prehospital diagnosis field-triage patient STEMI directly heart center PPCI facility recommend . In patient NONSTEMI previous trial indicate early angioplasty , within 72 hour symptom onset , associate improve outcome compare late angioplasty conservative therapy . No trial far able diagnose patient NONSTEMI prehospital phase immediately arrival hospital , triage directly PPCI . Implementation point-of-care ( POC ) test biomarkers may enable prehospital early inhospital establishment diagnosis NONSTEMI . The aim present trial identify patient NONSTEMI prehospital phase immediately arrival local hospital base ) symptom , b ) POC test c ) ECG finding randomize patient I ) PPCI , II ) medical therapy angiography/angioplasty within 72 hour ( today routine ) . Se detailed description</brief_summary>
	<brief_title>Acute Versus Subacute Angioplasty Patients With NON-ST-Elevation Myocardial Infarction</brief_title>
	<detailed_description>In present trial patient ) typical angina pectoris ( AP ) combine b1 ) rise biomarkers POC test ( prehospital/immediately inhospital ) and/or b2 ) ST-segment depression 0.2 mV two contiguous lead 0.1 mV four contiguous lead randomize I ) PPCI ( protocol STEMI patient ) II ) medical therapy angiography/angioplasty within 72 hour ( today routine practice ) . The primary purpose present trial threefold : 1 . To evaluate possible diagnose patient NONSTEMI prehospital phase immediately arrival hospital ( N=250 patient ) 2 . To compare combined endpoint mortality , re-infarction ( index admission readmitted ) , readmission Congestive Heart Failure ( CHF ) group I ( PPCI strategy ) group II ( routine strategy ) ( N=2500 patient ) . 3 . To compare mortality group I II ( N=4500 patient ) . Secondary purpose present trial : 1 . To evaluate whether difference primary endpoint patient randomize within 12 hour symptom onset . 2 . To evaluate whether difference primary endpoint patient randomize prehospital phase admission hospital , respectively . 3 . To evaluate whether difference primary endpoint patient final diagnosis AMI , adjudicate clinical event committee . 4 . To evaluate whether difference primary endpoint patient without diabetes , respectively . 5 . To compare combined endpoint mortality , readmission AMI , readmission CHF , readmission AP , revascularization ( plan index admission ) . 6 . To compare combined safety endpoint stroke serious bleed group I II . 7 . To evaluate difference frequency PCI CABG group I versus II . 8 . To compare total admission time group I II . 9 . To compare total cost group I II . 10 . To compare total duration patient sick leave group I II</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Angina Elevated biomarkers ( Pointofcare test ) either prehospital immediately admission STsegment depression 0.2mV two contiguous lead 0.1 mV four contiguous lead . Patient randomize either prehospital phase within 30 minute admission hospital Tachycardia &gt; 120 Age &lt; 18 &gt; 80 year Indication PPCI already fulfil Dementia Patient understand study information Presumed `` troponisme '' Left ventricular hypertrophy Known dialysis Previous CABG Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Myocardial infarction</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Prehospital emergency care</keyword>
	<keyword>Biological marker</keyword>
	<keyword>Troponin</keyword>
	<keyword>Point-of-Care system</keyword>
</DOC>